Krka, d. d. (LJSE: KRKG)

Market Cap	4.24B
Revenue (ttm)	1.90B
Net Income (ttm)	359.83M
Shares Out	30.75M
EPS (ttm)	11.67
PE Ratio	11.83
Forward PE	12.03
Dividend	7.50 (5.43%)
Ex-Dividend Date	Jul 23, 2024

Volume	5,135
Open	138.00
Previous Close	138.00
Day's Range	137.50 - 139.50
52-Week Range	109.00 - 150.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 30, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases. The company also provides non-prescription products for oral cavity and pharynx; cough and cold; a...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 10,284
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: KRKG

Financial Performance

In 2023, Krka, d. d.'s revenue was 1.81 billion, an increase of 5.18% compared to the previous year's 1.72 billion. Earnings were 313.95 million, a decrease of -13.58%.